TY - JOUR T1 - Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer. JF - Oncotarget Y1 - 2016 A1 - Puchades-Carrasco, Leonor A1 - Jantus-Lewintre, Eloisa A1 - PĂ©rez-Rambla, Clara A1 - Garcia-Garcia, Francisco A1 - Lucas, Rut A1 - Calabuig, Silvia A1 - Blasco, Ana A1 - Dopazo, Joaquin A1 - Camps, Carlos A1 - Pineda-Lucena, Antonio KW - Adult KW - Aged KW - Biomarkers, Tumor KW - Carcinoma, Non-Small-Cell Lung KW - Disease Progression KW - Female KW - Humans KW - Lung Neoplasms KW - Male KW - metabolomics KW - Middle Aged KW - Proton Magnetic Resonance Spectroscopy AB -

Lung cancer (LC) is responsible for most cancer deaths. One of the main factors contributing to the lethality of this disease is the fact that a large proportion of patients are diagnosed at advanced stages when a clinical intervention is unlikely to succeed. In this study, we evaluated the potential of metabolomics by 1H-NMR to facilitate the identification of accurate and reliable biomarkers to support the early diagnosis and prognosis of non-small cell lung cancer (NSCLC).We found that the metabolic profile of NSCLC patients, compared with healthy individuals, is characterized by statistically significant changes in the concentration of 18 metabolites representing different amino acids, organic acids and alcohols, as well as different lipids and molecules involved in lipid metabolism. Furthermore, the analysis of the differences between the metabolic profiles of NSCLC patients at different stages of the disease revealed the existence of 17 metabolites involved in metabolic changes associated with disease progression.Our results underscore the potential of metabolomics profiling to uncover pathophysiological mechanisms that could be useful to objectively discriminate NSCLC patients from healthy individuals, as well as between different stages of the disease.

VL - 7 IS - 11 U1 - https://www.ncbi.nlm.nih.gov/pubmed/26883203?dopt=Abstract ER -